A 58-year-old man presents with progressive loss of vision in the superior temporal quadrant of both eyes. On examination, he has normal visual acuity and intraocular pressures of 24 mmHg bilaterally. Fundoscopy reveals early optic disc cupping. Which investigation is most appropriate to confirm the diagnosis and establish baseline parameters for monitoring disease progression?

## Investigation of Choice for Glaucomatous Visual Field Defects ### Clinical Context The patient presents with a **superior temporal quadrant defect** (arcuate pattern), elevated intraocular pressure, and optic disc cupping—classic features of **primary open-angle glaucoma (POAG)**. The investigation must: 1. Detect and map the visual field defect accurately 2. Quantify severity for baseline documentation 3. Enable reproducible monitoring over time ### Why Automated Static Perimetry (Humphrey) is the Gold Standard **Key Point:** Automated static perimetry (ASP) is the **investigation of choice** for documenting and monitoring glaucomatous visual field defects. | Feature | Automated Static Perimetry | Confrontation | Amsler Grid | Tangent Screen | |---------|---------------------------|---------------|-------------|----------------| | **Sensitivity** | 95–98% for early defects | 50–60% | Not applicable | 70–80% | | **Quantification** | Precise dB values, MD, PSD | Qualitative only | Not for VF mapping | Semiquantitative | | **Reproducibility** | Excellent (gold standard) | Poor | N/A | Moderate | | **Glaucoma monitoring** | Standard of care | Inadequate | Not used | Rarely used | | **Time required** | 20–30 min | 2–3 min | 1–2 min | 10–15 min | | **Learning curve** | Steep (patient cooperation) | None | None | Moderate | **High-Yield:** The **Humphrey 24-2 or 30-2 program** is the **standard-of-care investigation** for: - Initial diagnosis and staging of glaucoma - Detecting arcuate defects (superior/inferior nasal step) - Quantifying mean deviation (MD) and pattern standard deviation (PSD) - Establishing baseline for 6–12 monthly monitoring - Detecting progression (≥3 dB decline in MD over 2 years = significant progression) ### Diagnostic Yield in This Case The arcuate superior temporal defect (respecting the horizontal meridian) is **pathognomonic for glaucoma**. ASP will: - Confirm the defect in both eyes - Measure severity (early, moderate, advanced) - Document baseline indices for future comparison - Guide treatment intensity **Clinical Pearl:** In glaucoma, the **optic nerve head changes precede visual field defects by 5–7 years**. Once VF loss appears, ASP is essential to prevent further irreversible damage through aggressive IOP lowering. ### Mnemonic for VF Investigation Selection **ASAP for Glaucoma** = **Automated Static Automated Perimetry** for **Glaucoma** (and other optic nerve/retinal diseases requiring quantitative VF mapping). [cite:Khurana Ophthalmology Ch 10]